Skip to content
2000
Volume 19, Issue 1
  • ISSN: 1570-193X
  • E-ISSN: 1875-6298

Abstract

Hydroxychloroquine (HCQ) is an extremely important drug used for the treatment of various ailments. WHO listed it as one of the essential drugs. The utility of hydroxychloroquine (HCQ) as prophylaxis of COVID19, although debated, is well known. We have reviewed synthetic strategies for the industrial and academic synthesis of HCQ and its key intermediates like 4,7-dichloroquinoline (4,7- DCQ) and 2-((4-aminopentyl)(ethyl)amino)ethan-1-ol 9 (aka hydroxy novaldiamine; HNDA). The review is expected to provide the right perspective of state-of-the-art knowledge in this field so that further developments are possible.

Loading

Article metrics loading...

/content/journals/mroc/10.2174/1570193X18666210204113412
2022-01-01
2025-04-02
Loading full text...

Full text loading...

/content/journals/mroc/10.2174/1570193X18666210204113412
Loading

  • Article Type:
    Review Article
Keyword(s): 4; 7-DCQ; coronavirus disease; Covid-19; HNDA; Hydroxychloroquine (HCQ); toxic chloroquine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test